Join to View Full Profile
RetiredCary, NC 27519
Dr. Ayscue is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Specialized in Pathology, Immunopathology, Hematopathology and Transfusion medicine. I left Pathology to do a Family Medicine Residency and worked in small emergency departments until I retired.
Education & Training
ECU Health Medical Center/East Carolina UniversityResidency, Family Medicine, 2002 - 2005
University of North Carolina HospitalsFellowship, Blood Banking/Transfusion Medicine, 1996 - 1997- University of North Carolina HospitalsResidency, Immunopathology, 1994 - 1995
- University of North Carolina HospitalsResidency, Pathology-Anatomic and Clinical, 1989 - 1994
University of North Carolina at Chapel Hill School of MedicineClass of 1989
Certifications & Licensure
NC State Medical License 1994 - 2017
American Board of Pathology Anatomic Pathology & Clinical Pathology
American Board of Family MedicineFamily Medicine
Awards, Honors, & Recognition
- Phillip Blatt Teaching Award UNC Department of Pathology, 2002
- NIH K08 grant for 5 years NIH, 1994-1999
- Graduated with Honors from UNC-CH Medical School UNC-CH Medical School, 1989
- Join now to see all
Publications & Presentations
PubMed
- 33 citationsFollicular lymphoma with a burkitt translocation--predictor of an aggressive clinical course: a case report and review of the literature.Peter M. Voorhees, Kathryn A. Carder, Scott V. Smith, Lanier H. Ayscue, Kathleen W. Rao
Archives of Pathology & Laboratory Medicine. 2004-02-01 - 90 citationsRole of Estrogen Receptor in the Regulation of Ecto-5′-Nucleotidase and Adenosine in Breast CancerJozef Spychala, Eduardo Lazarowski, Anna Ostapkowicz, Lanier H. Ayscue, Aiwen Jin
Clinical Cancer Research. 2004-01-15 - 56 citationsInhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II geneJing Jin Gu, Sander Stegmann, Karen Gathy, Robert D. Murray, Josée Laliberté
The Journal of Clinical Investigation. 2000-08-15
Grant Support
- Regulation Of Deoxycytidine Kinase In Leukemic CellsNational Cancer Institute1994–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
